HCA Healthcare (NYSE:HCA) Issues FY 2024 Earnings Guidance

HCA Healthcare (NYSE:HCA) updated its FY 2024 earnings guidance on Friday. The company provided earnings per share (EPS) guidance of 21.600-22.800 for the period, compared to the consensus estimate of 22.620. The company issued revenue guidance of $69.8 billion-$71.8 billion, compared to the consensus revenue estimate of $70.9 billion.

HCA Healthcare Trading Down 8.9 %

Shares of HCA stock opened at $363.55 on Monday. The company has a quick ratio of 0.94, a current ratio of 1.06 and a debt-to-equity ratio of 27.11. The firm has a market capitalization of $95.22 billion, a P/E ratio of 18.12, a P/E/G ratio of 1.52 and a beta of 1.67. HCA Healthcare has a twelve month low of $220.55 and a twelve month high of $417.14. The stock’s fifty day simple moving average is $395.06 and its 200 day simple moving average is $352.71.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be given a dividend of $0.66 per share. The ex-dividend date of this dividend is Friday, December 13th. This represents a $2.64 annualized dividend and a yield of 0.73%. HCA Healthcare’s dividend payout ratio is presently 13.16%.

Wall Street Analyst Weigh In

Several brokerages recently weighed in on HCA. KeyCorp began coverage on shares of HCA Healthcare in a research note on Friday, October 11th. They issued an “overweight” rating and a $475.00 price objective on the stock. Morgan Stanley began coverage on HCA Healthcare in a research note on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price objective on the stock. Oppenheimer raised their price target on shares of HCA Healthcare from $345.00 to $390.00 and gave the stock an “outperform” rating in a report on Wednesday, July 24th. Barclays increased their price objective on shares of HCA Healthcare from $376.00 to $396.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 24th. Finally, UBS Group upped their price target on shares of HCA Healthcare from $405.00 to $438.00 and gave the company a “buy” rating in a research report on Wednesday, August 14th. Five analysts have rated the stock with a hold rating, twelve have given a buy rating and four have issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $377.17.

Insiders Place Their Bets

In other HCA Healthcare news, SVP Kathleen M. Whalen sold 2,987 shares of the company’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $363.51, for a total value of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at approximately $3,436,623.54. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other news, SVP Kathleen M. Whalen sold 2,987 shares of the firm’s stock in a transaction on Wednesday, July 31st. The stock was sold at an average price of $363.51, for a total transaction of $1,085,804.37. Following the completion of the sale, the senior vice president now directly owns 9,454 shares of the company’s stock, valued at $3,436,623.54. This trade represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 8,358 shares of the stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total transaction of $3,221,340.36. Following the transaction, the executive vice president now owns 29,678 shares of the company’s stock, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.